Pfizer Inc (PFE)
30.78
+0.60
(+1.97%)
USD |
NYSE |
Jul 26, 16:00
30.73
-0.04
(-0.15%)
After-Hours: 20:00
Pfizer Free Cash Flow: 5.106B for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | 5.106B |
December 31, 2023 | 4.793B |
September 30, 2023 | 8.178B |
June 30, 2023 | 10.66B |
March 31, 2023 | 20.21B |
December 31, 2022 | 26.03B |
September 30, 2022 | 23.36B |
June 30, 2022 | 28.44B |
March 31, 2022 | 31.78B |
December 31, 2021 | 29.87B |
September 30, 2021 | 29.77B |
June 30, 2021 | 21.14B |
March 31, 2021 | 13.48B |
December 31, 2020 | 12.18B |
September 30, 2020 | 10.96B |
June 30, 2020 | 13.22B |
March 31, 2020 | 12.15B |
December 31, 2019 | 10.54B |
September 30, 2019 | 10.96B |
June 30, 2019 | 11.81B |
March 31, 2019 | 13.21B |
December 31, 2018 | 13.69B |
September 30, 2018 | 16.00B |
June 30, 2018 | 15.60B |
March 31, 2018 | 14.92B |
Date | Value |
---|---|
December 31, 2017 | 14.58B |
September 30, 2017 | 13.54B |
June 30, 2017 | 13.55B |
March 31, 2017 | 13.91B |
December 31, 2016 | 14.19B |
September 30, 2016 | 13.16B |
June 30, 2016 | 13.55B |
March 31, 2016 | 14.26B |
December 31, 2015 | 13.19B |
September 30, 2015 | 14.16B |
June 30, 2015 | 13.37B |
March 31, 2015 | 13.30B |
December 31, 2014 | 15.50B |
September 30, 2014 | 15.52B |
June 30, 2014 | 17.19B |
March 31, 2014 | 16.88B |
December 31, 2013 | 16.22B |
September 30, 2013 | 15.36B |
June 30, 2013 | 14.50B |
March 31, 2013 | 14.78B |
December 31, 2012 | 15.33B |
September 30, 2012 | 15.41B |
June 30, 2012 | 14.67B |
March 31, 2012 | 16.49B |
December 31, 2011 | 18.36B |
Free Cash Flow Range, Past 5 Years
4.793B
Minimum
Dec 2023
31.78B
Maximum
Mar 2022
16.99B
Average
13.22B
Median
Jun 2020
Free Cash Flow Benchmarks
Amgen Inc | 7.098B |
Johnson & Johnson | 18.23B |
Sarepta Therapeutics Inc | -653.88M |
Viking Therapeutics Inc | -54.87M |
Moderna Inc | -3.672B |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 1.09B |
Cash from Investing (Quarterly) | 1.732B |
Cash from Financing (Quarterly) | -4.931B |
Free Cash Flow Per Share (Quarterly) | 0.0678 |
Free Cash Flow to Equity (Quarterly) | 2.523B |
Free Cash Flow to Firm (Quarterly) | 990.39M |
Free Cash Flow Yield | 2.92% |